Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Upson

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecular Cancer Research : MCR|August 27, 2005
Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosisCharles E Ducker, John J Upson, Kevin J French, et al.
Oncogene|October 19, 2004
Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferaseCharles E Ducker, Erin M Stettler, Kevin J French, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2006
Antitumor activity of sphingosine kinase inhibitorsKevin J French, John J Upson, Staci N Keller, et al.
Digestive Diseases and Sciences|December 7, 2007
Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinaseLynn W Maines, Leo R Fitzpatrick, Kevin J French, et al.
Journal of Cellular Physiology|September 25, 2004
Optimized procedures for microarray analysis of histological specimens processed by laser capture microdissectionJohn J Upson, Radka Stoyanova, Harry S Cooper, et al.
Journal of Cellular Physiology|September 25, 2004
Use of RNA amplification in the optimal characterization of global gene expression using cDNA microarraysRadka Stoyanova, John J Upson, Christos Patriotis, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 12, 2010
Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2Kevin J French, Yan Zhuang, Lynn W Maines, et al.
Inflammopharmacology|October 12, 2010
Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinaseLeo R Fitzpatrick, Cecelia Green, Elizabeth E Frauenhoffer, et al.
Journal of Cardiovascular Pharmacology|December 13, 2012
Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and miceLisa A Morgan, Alan R Olzinski, John J Upson, et al.
Frontiers in Pharmacology|July 12, 2012
Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stressMelissa H Costell, Nicolas Ancellin, Roberta E Bernard, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Cancer Research : MCR|August 27, 2005
Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosisCharles E Ducker, John J Upson, Kevin J French, et al.
Oncogene|October 19, 2004
Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferaseCharles E Ducker, Erin M Stettler, Kevin J French, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2006
Antitumor activity of sphingosine kinase inhibitorsKevin J French, John J Upson, Staci N Keller, et al.
Digestive Diseases and Sciences|December 7, 2007
Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinaseLynn W Maines, Leo R Fitzpatrick, Kevin J French, et al.
Journal of Cellular Physiology|September 25, 2004
Optimized procedures for microarray analysis of histological specimens processed by laser capture microdissectionJohn J Upson, Radka Stoyanova, Harry S Cooper, et al.
Journal of Cellular Physiology|September 25, 2004
Use of RNA amplification in the optimal characterization of global gene expression using cDNA microarraysRadka Stoyanova, John J Upson, Christos Patriotis, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 12, 2010
Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2Kevin J French, Yan Zhuang, Lynn W Maines, et al.
Inflammopharmacology|October 12, 2010
Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinaseLeo R Fitzpatrick, Cecelia Green, Elizabeth E Frauenhoffer, et al.
Journal of Cardiovascular Pharmacology|December 13, 2012
Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and miceLisa A Morgan, Alan R Olzinski, John J Upson, et al.
Frontiers in Pharmacology|July 12, 2012
Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stressMelissa H Costell, Nicolas Ancellin, Roberta E Bernard, et al.
Pageof 1